Last --
Change Today 0.00 / 0.00%
Volume 0.0
CCHXF On Other Exchanges
Symbol
Exchange
OTC US
All times are local (Market data is delayed by at least 15 minutes).

conjuchem biotechnologies in (CCHXF) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CONJUCHEM BIOTECHNOLOGIES IN (CCHXF)

Related News

No related news articles were found.

conjuchem biotechnologies in (CCHXF) Related Businessweek News

No Related Businessweek News Found

conjuchem biotechnologies in (CCHXF) Details

ConjuChem Biotechnologies Inc., a biotechnology company, engages in the discovery and development of medicines from therapeutic peptides based on its bioconjugation platform technology. The company develops compounds to treat various disorders, such as diabetes, human growth deficiencies, and HIV/AIDS. Its bioconjugation platforms include drug affinity complex (DAC) and preformed conjugate drug affinity complex (PC-DAC), which have the ability to harness the therapeutic potential of peptides. The company develops PC-DAC: Exendin-4, a glucagon-like peptide-1 (GLP-1) homolog and an agonist for the GLP-1 receptor, which protects peptides from peptidase degradation, as well as prevents kidney excretion in order to make development of peptide drugs practicable. It also develops PC-DAC: Insulin, a hormone, for controlling the glucose uptake from blood; and DAC: HIV conjugate, a protein used for membrane fusion and infection process. The company was formerly known as ConjuChem Inc. and changed its name to ConjuChem Biotechnologies Inc. in May 2006. ConjuChem Biotechnologies Inc. was founded in 1997 and is based in Montreal, Canada.

20 Employees
Last Reported Date: 01/29/10
Founded in 1997

conjuchem biotechnologies in (CCHXF) Top Compensated Officers

Executive Chairman, Chairman of Special Commi...
Total Annual Compensation: --
Vice President of Finance
Total Annual Compensation: --
Vice President and General Counsel
Total Annual Compensation: --
Secretary
Total Annual Compensation: --
Executive Vice President of Research and Deve...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCHXF:US $0.00 USD 0.00

CCHXF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CCHXF.
View Industry Companies
 

Industry Analysis

CCHXF

Industry Average

Valuation CCHXF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1,132.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 179.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONJUCHEM BIOTECHNOLOGIES IN, please visit www.conjuchem.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.